Compare ANIK & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIK | BWG |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.5M | 139.9M |
| IPO Year | 1993 | N/A |
| Metric | ANIK | BWG |
|---|---|---|
| Price | $9.62 | $8.53 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 178.2K | 53.8K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.37% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $112,806,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.55 | N/A |
| 52 Week Low | $7.87 | $6.86 |
| 52 Week High | $18.37 | $8.65 |
| Indicator | ANIK | BWG |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 56.87 |
| Support Level | $9.76 | $8.22 |
| Resistance Level | $10.17 | $8.55 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 40.00 | 85.71 |
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.